ardenermin

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameardenermin
Drug Alias NameB-Lymphocyte Stimulator (HGS)BLyS (HGS)neutrokine alphaB-cell stimulator (HGS)neutrokine-alpha (134-285) +[7] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsImmunologic Deficiency Syndromes

Other Information

ATC CodeN/A
Related LinksN/A